treatment of NAFLD
initiates NAFLD
NAFLD pathogenesis
addition NAFLD
liver cancer
nonalcoholic fatty liver disease Development of anti-microRNA therapeutic
novel pharmaceutical treatment
nonalcoholic steatohepatitis
widespread disease
pharmacological treatment
excessive accumulation of liver triglycerides
miR
oligonucleotide antisense treatment
effective pharmaceutical
excess microRNA
brain metabolism
NASH
cirrhosis
suppression
corresponding impact
discovery
inherited mouse models
links